Drug Type Small molecule drug |
Synonyms Compound 9d(Chinese Academy of Medical Sciences and Peking Union Medical College) |
Target |
Action inhibitors |
Mechanism CES2 inhibitors(carboxylesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H35NO5 |
InChIKeyXFBJUMZGUOUWSC-UHFFFAOYSA-N |
CAS Registry3037959-47-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | China | 21 May 2025 | |
| Colitis, Ulcerative | Preclinical | China | 21 May 2025 | |
| Drug-induced diarrhea | Preclinical | China | 21 May 2025 | |
| Drug-induced diarrhea | Preclinical | China | 21 May 2025 |





